Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging

Figure 1 Kaplan-Meier survival curves for the Barcelona Clinic Liver Cancer staging system for the whole cohort. There is a significant difference in survival between Barcelona Clinic Liver Cancer stages A and B patients. BCLC: Barcelona Clinic Liver Cancer stage.

Figure 2 Scatter plot graph for survival and alpha-fetoprotein ≥ 200 ng/mL in the whole cohort. Alpha-fetoprotein level was inversely correlated with patients’ survival. AFP: Alpha-fetoprotein.

Figure 3 Kaplan-Meier survival curves for modified Barcelona Clinic Liver Cancer for the whole cohort. There is a significant difference in survival between the three subgroups of either Barcelona Clinic Liver Cancer stage A or B patients. AFP: alpha-fetoprotein; BCLC: Barcelona Clinic Liver Cancer stage.